Similar articles

• Ribonuclease inhibition of mevalonic acid utilization.

  WRIGHT LD, CLELAND M, DUTTA BN. WRIGHT LD, et al. Proc Soc Exp Biol Med. 1958 Jun;98(2):425-7. doi: 10.3181/00379727-98-24066. Proc Soc Exp Biol Med. 1958. PMID: 13554668 No abstract available.
• Relationship between mevalonic acid utilization and ATP content in liver homogenates pretreated with ribonuclease.

  WRIGHT LD, LOEB M, NORTON JS. WRIGHT LD, et al. Proc Soc Exp Biol Med. 1959 Aug-Sep;101:866-7. doi: 10.3181/00379727-101-25122. Proc Soc Exp Biol Med. 1959. PMID: 13846091 No abstract available.
• Relationship between ribonuclease and certain anionic polymers in utilization of mevalonic acid by liver homogenates.

  WRIGHT LD, LOEB M, HANSON R. WRIGHT LD, et al. Proc Soc Exp Biol Med. 1960 Mar;103:546-9. doi: 10.3181/00379727-103-25591. Proc Soc Exp Biol Med. 1960. PMID: 13846090 No abstract available.
• Protamine and conversion of mevalonic acid to cholesterol by liver homogenates.

  WRIGHT LD, HANSON R. WRIGHT LD, et al. Proc Soc Exp Biol Med. 1960 Apr;103:854-7. doi: 10.3181/00379727-103-25695. Proc Soc Exp Biol Med. 1960. PMID: 13846089 No abstract available.
• ATP and the conversion of mevalonic acid to cholesterol and precursors by liver homogenates.

  WRIGHT LD, LOEB M. WRIGHT LD, et al. Proc Soc Exp Biol Med. 1959 Oct-Dec;102:540-2. doi: 10.3181/00379727-102-25311. Proc Soc Exp Biol Med. 1959. PMID: 13846092 No abstract available.